Best companies in Watertown Town, MA

Capitalizing on breakthrough synthetic chemistry, Tetraphase Pharmaceuticals is leveraging a dynamic drug engine targeted at several significant disease categories.

Athenahealth is a leading provider of internet-based business services for physician practices. The Company's service offerings are based on proprietary web-native practice management and electronic health record (EHR) software, a continuously updated payer knowledge-base, integrated back-office service operations, and live patient communications services.

EyePoint Pharmaceuticals, Inc., is a pharmaceutical company committed to developing and commercializing innovative therapeutics to help improve the lives of patients with serious eye disorders.

Enanta Pharmaceuticals, Inc., a research and development company, engages in the discovery, development, and promotion of small molecule drugs in the areas of anti-infective. It develops protease, NS5A, polymerase, and cyclophilin-based inhibitors for the treatment of hepatitis C virus (HCV). The company also develops ABT-450/r, an oral protease inhibitor for the treatment of hepatitis C (HCV) infection. In addition, it develops Bicyclolides, a macrolide antibiotic, which overcomes bacterial resistance; and EDP-420, a bicyclolide antibiotic for the treatment of community-acquired pneumonia. The company's antibacterial focus areas include superbugs, respiratory tract infections, and intravenous and oral treatments for hospital and community MRSA. The company has strategic alliances with Abbott Laboratories; and Shionogi & Co., LTD. Enanta Pharmaceuticals, Inc. was formerly known as NovirX, Inc. and changed its name to Enanta Pharmaceuticals, Inc. in May 1999. The company was founded in 1998 and is based in Watertown, Massachusetts.

Liaison helps higher education institutions identify, recruit and enroll students with admissions management and marketing automation software and services.

FORMA Therapeutics is a biopharmaceutical company integrating transformative biology and chemistry to unlock targets and pathways that have been validated through genomic medicine as root causes or major drivers of human cancers. FORMA's approach to accessing such high value drug targets, many of which pose significant challenges to conventional discovery approaches, is rooted in the concerted integration of its innovative drug discovery technologies and oncology expertise, enabling screening, discovery and rational development of a generation of small molecule drug candidates with cellular mechanisms of action. FORMA is building a pipeline of therapeutics directed at Achilles heels in human cancers, such as key targets associated with cancer stem cells, tumor cell metabolism, programmed cell death or epigenetic disease mechanisms. FORMA builds on the vision of its academic founders: Stuart Schreiber, Todd Golub and Michael Foley, each of the Broad Institute of Harvard and MIT. FORMA leverages its innovative drug discovery platform to address challenging targets and develop a robust internal pipeline of breakthrough oncology drugs.

Provider of an industrial 3D printing platform intended to simplify the manufacturing process for 3D printing. The company's platform sells a wide range of 3D printers, along with materials that include onyx, fiberglass and various metals, enabling designers and engineers liberate themselves from decades-old, slow part creation processes.

Developing Pentarins to make a difference in the treatment of patients with solid tumor malignancies

VHB's passionate engineers, scientists, planners, and designers are working together to deliver value to our clients and help shape our communities in a meaningful way.

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company's proprietary technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of CRS. The therapeutic embedded within LYR-210 and LYR-220 is mometasone furoate, which is the active ingredient in various FDA-approved drugs and has a well-established efficacy and safety profile.

Better design, together is an ongoing mission rather than a final destination that leaves us room to define and redefine what better means. Better is forward-looking, it requires a growth mindset, and it is not prescriptive about what is best for our clients or the communities we serve.

Perkins is a progressive, multi-faceted organization committed to improving the lives of people with blindness and deafblindness all around the world. Our five areas of focus operate every day to carry out Perkins' aspirational mission. Our organization is driven by a proven team of experts. Our history of excellence pushes us to actively seek the next innovation the world holds. We are Perkins - ever evolving to meet the challenge. The Perkins mission is to provide education and services that build productive, meaningful lives for children and adults around the world who are blind, deafblind or visually impaired, including those with additional disabilities. Areas of Focus: Perkins consists of five distinct lines of business that collaborate on local, national and global levels that work together every day to change what it means to be blind. Perkins School for the Blind, which serves approximately 200 students on campus, and operates as the headquarters for our Community Services programs including itinerant services, independence courses for public school students, evaluations and assessments for communities, and training for professionals. Perkins International, which impacts the lives of thousands of children, families, educators and professionals every year. Perkins nternational works to develop sustainable capacity in 67 countries through local, on-the-ground partnerships, and provides resources, training and advocacy to improve the lives of the 4.5 million children around the world without access to education due to blindness. Perkins Solutions, which provides innovative assistive technology products and consulting services to people, organizations and governments around the world to empower people who are blind or visually impaired to reach their full potential. Product offerings range from the classic mechanical Perkins Brailler to cutting-edge tools such as the LightAide. Perkins eLearning, an online portal designed to provide resources and support to anyone, anywhere, in the field of blindness education. Perkins eLearning leverages their reputation as a teacher of teachers by offering high-quality webcasts and webinars on a variety of topics. They also provide professional development and graduate level credits to educators through online workshops. A recent grant from the Gates Foundation for Perkins eLearning is providing financial support for this critical sharing of resources. Perkins Library, which circulates more than 530,000 items in braille, audio, electronic and large print formats to about 28,000 patrons in the U.S. The Library has served patrons since 1835 and is one of the oldest accessibility services in the country.

What if we stop trying to change the patient, and changed the pill instead?

RESIDENTIAL SERVICES: BEAVERBROOK STEP SUPPORTED OVER 100 INDIVIDUALS ENABLING TRAINING, EDUCATION, SKILL BUILDING, MEDICAL AND PSYCHIATRIC TREATMENT, RECREATION, RELATIONSHIP BUILDING AND COMMUNITY INTEGRATION IN OVER 25 SETTINGS. ADDITIONALLY, BEAVERBROOK STEP ENSURED THAT INDIVIDUALS WERE ABLE TO PARTICIPATE IN THEIR COMMUNITIES AS VALUED MEMBERS. THE ORGANIZATION MAINTAINED ATTRACTIVE AND AFFORDABLE HOMES, EMPLOYED A WELL-SKILLED STAFF AND CONDUCTED ITSELF IN RESPONSIBLE, CREATIVE WAYS.

United Electric Controls provides gas leak detectors, pressure switches, temperature switches, safety transmitters, and sensors for the process, discrete, semiconductor, aerospace, and defense industries.

J.C. Cannistraro, LLC is a privately held mechanical construction firm headquartered in Watertown, Massachusetts. The company provides HVAC, fire Protection and facilities maintenance services for large mechanical plants at hospitals, universities, laboratories, and many other facilities.

A+ Rating with the BBB!! Member of the Waltham Chamber of Commerce! Local Moves: No job is too big for us, more often than not ocal moves can be scheduled same day! We are your last minute moving experts! Long Distance: Down the coast or a...

We thrive on tackling challenging projects for organizations whose work makes a difference in people's lives and the world. We create state-of-the-art facilities by providing tightly integrated and coordinated engineering design services for every aspect of the built environment.

Fighting antimicrobial resistance with a Next-Generation Phenotyping (NGP) platform that enables personalized antibiotic therapies for patients.